Osteogenesis Imperfecta Global Clinical Trials Review, H1, 2018
April 2018
53
About the Report
About the Report
Osteogenesis Imperfecta Global Clinical Trials Review, H1, 2018
Summary
GlobalData's clinical trial report, "Osteogenesis Imperfecta Global Clinical Trials Review, H1, 2018" provides an overview of Osteogenesis Imperfecta clinical trials scenario. This report provides top line data relating to the clinical trials on Osteogenesis Imperfecta. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Products
Companies
Mereo Biopharma Group Plc Novartis AG ICON Plc Eli Lilly and Co Amgen Inc Sparks Sanofi Allergan Plc Axellus A/S Arthritis Research UK
Table of Contents
Table of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
GlobalData Clinical Trials Report Coverage 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Osteogenesis Imperfecta to Genetic Disorders Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Osteogenesis Imperfecta to Genetic Disorders Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Osteogenesis Imperfecta Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profile Snapshots 28
Appendix 51
Abbreviations 51
Definitions 51
Research Methodology 52
Secondary Research 52
About GlobalData 53
Contact Us 53
Source 53
List of Figure
List of Figures
Osteogenesis Imperfecta Therapeutics, Global, Clinical Trials by Region (%), 2018* 6
Osteogenesis Imperfecta Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 7
Osteogenesis Imperfecta Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 8
Osteogenesis Imperfecta Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2018* 9
Osteogenesis Imperfecta Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 10
Osteogenesis Imperfecta Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 11
Osteogenesis Imperfecta Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 12
Osteogenesis Imperfecta Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2018* 13
Proportion of Osteogenesis Imperfecta to Genetic Disorders Clinical Trials, G7 Countries (%), 2018* 14
Osteogenesis Imperfecta Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 15
Osteogenesis Imperfecta Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 16
Proportion of Osteogenesis Imperfecta to Genetic Disorders Clinical Trials, E7 Countries (%), 2018* 17
Osteogenesis Imperfecta Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 18
Osteogenesis Imperfecta Therapeutics, Global, Clinical Trials by Phase (%), 2018* 19
Osteogenesis Imperfecta Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 20
Osteogenesis Imperfecta Therapeutics, Global, Clinical Trials by Trial Status, 2018* 21
Osteogenesis Imperfecta Therapeutics Clinical Trials, Global, by End Point Status, 2018* 22
Osteogenesis Imperfecta Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 23
Osteogenesis Imperfecta Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 24
Osteogenesis Imperfecta Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 25
Osteogenesis Imperfecta Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 26
Osteogenesis Imperfecta Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 27
GlobalData Methodology 52
List of Table
List of Tables
Osteogenesis Imperfecta Therapeutics, Global, Clinical Trials by Region, 2018* 6
Osteogenesis Imperfecta Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 7
Osteogenesis Imperfecta Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 8
Osteogenesis Imperfecta Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2018* 9
Osteogenesis Imperfecta Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 10
Osteogenesis Imperfecta Therapeutics Clinical Trials, North America, Top Countries, 2018* 11
Osteogenesis Imperfecta Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 12
Osteogenesis Imperfecta Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 13
Proportion of Osteogenesis Imperfecta to Genetic Disorders Clinical Trials, G7 Countries (%), 2018* 14
Osteogenesis Imperfecta Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 15
Osteogenesis Imperfecta Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 16
Proportion of Osteogenesis Imperfecta to Genetic Disorders Clinical Trials, E7 Countries (%), 2018* 17
Osteogenesis Imperfecta Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 18
Osteogenesis Imperfecta Therapeutics, Global, Clinical Trials by Phase, 2018* 19
Osteogenesis Imperfecta Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 20
Osteogenesis Imperfecta Therapeutics, Global, Clinical Trials by Trial Status, 2018* 21
Osteogenesis Imperfecta Therapeutics Clinical Trials, Global, by End Point Status, 2018* 22
Osteogenesis Imperfecta Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 23
Osteogenesis Imperfecta Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 24
Osteogenesis Imperfecta Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 25
Osteogenesis Imperfecta Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 26
Osteogenesis Imperfecta Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 27
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.